Increased S100β in the cerebrospinal fluid of patients with frontotemporal dementia

Neuroscience Letters

Volumn 235, Issue 1-2, 1997, Pages 5-8

  Green, A J E ^a   Harvey, R J ^a   Thompson, E J ^a   Rossor, M N ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Alzheimer's disease; Astrocytes; Cerebrospinal fluid; Frontotemporal dementia; S100

Indexed keywords

PROTEIN S 100; NERVE GROWTH FACTOR; S 100 CALCIUM BINDING PROTEIN BETA SUBUNIT; S-100 CALCIUM-BINDING PROTEIN BETA SUBUNIT;

ADULT; AGED; ARTICLE; ASTROCYTE; ASTROCYTOSIS; BRAIN ATROPHY; CELL DIFFERENTIATION; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; DEMENTIA; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FRONTAL BONE; HUMAN; MALE; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; TEMPORAL BONE; ALZHEIMER DISEASE; BRAIN DISEASE; CEREBROSPINAL FLUID; FRONTAL LOBE; INFLAMMATION; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; TEMPORAL LOBE;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ASTROCYTES; BRAIN DISEASES; DEMENTIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FRONTAL LOBE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; RETROSPECTIVE STUDIES; S100 PROTEINS; TEMPORAL LOBE;

EID: 0030609159     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00701-5     Document Type: Article

References (15)

1. Fano G., Biocca S., Fulle S., Mariggio M., Belia S., Calissano P. The S-100: a protein family in search of a function. Prog. Neurobiol. 4:1995;71-82.
2. Folstein M., Folstein S., McHughs P. The 'Mini mental state' a practical method for grading the cognitive state of patients for the clinician. J. Psychol. Res. 12:1975;189-198.
3. Green A.J.E., Keir G., Thompson E.J. A specific and sensitive ELISA for measuring S-100β in cerebrospinal fluid. J. Immunol. Methods. 205:1997;35-41.
4. Lamers K.J.B., van Engelen B.G.M., Gabreels F.J.M., Hommes O.R., Borm G.F., Wevers R.A. Cerebrospinal neuron specific enolase, S-100 and myelin basic protein in neurological disorders. Acta Neurol. Scand. 92:1995;247-251.
5. Mandybur T.I., Chuirazze C.C. Astrocytes and the plaques of Alzheimer's disease. Neurology. 40:1990;635-639.
6. Mann D.M.A., South P.W., Snowden J.S., Neary D. Dementia of frontal lobe type: neuropathology and immunohistochemistry. J. Neurol. Neurosurg. Psychiatry. 56:1993;605-614.
7. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 34:1984;939-944.
8. Mokuno K., Kato K., Kawai K., Matsuoka Y., Sobue I. Neuron-specific enolase and S-100 protein levels in cerebrospinal fluid of patients with various neurological diseases. J. Neurol. Sci. 60:1983;443-451.
9. Mrak R.E., Sheng J.E., Griffin W.S.T. Glial cytokines in Alzheimer's disease: review and pathological implications. Hum. Pathol. 26:1995;816-823.
10. Noppe M., Crols R., Andries D., Lowenthal A. Determination in human cerebrospinal fluid of glial fibrillary acidic protein, S-100 and myelin basic protein as indices of non-specific or specific central nervous tissue pathology. Clin. Chim. Acta. 155:1986;143-150.
11. Rossor M.N. Molecular pathology of Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry. 56:1993;583-586.
12. Sheng J.G., Mrak R.E., Griffin W.S.T. S-100β protein expression in Alzheimer's disease: potential role in the pathogenesis of neuritic plaques. Neurosci. Res. 39:1994;398-404.
13. The Lund and Manchester Groups., Clinical and neuropathological criteria for frontotemporal dementia, J. Neurol. Neurosurg. Psychiatry, 57 (1994) 416-418.
14. Van Eldik L.J., Griffin W.S.T. S-100β expression in Alzheimer's disease: relation to neuropathology in brain regions. Biochim. Biophys. Acta. 1223:1994;398-403.
15. Zimmer D.B., Cornwall E.H., Landar A., Song W. The S100 protein family: history, function and expression. Brain Res. Bull. 37(4):1995;417-429.